Morepen to Hire 1,000 Medical Reps to Boost Formulations Business

By By Rediff Money Desk, New Delhi
Apr 11, 2025 11:51
Morepen Laboratories plans to hire over 1,000 medical representatives in the next three years to strengthen its formulations business in India's growing pharmaceutical market.
New Delhi, Apr 11 (PTI) Morepen Laboratories on Friday said it will add more than 1,000 medical representatives over the next three years, with over 200 team members expected to join in FY26 alone.

The company aims to strengthen its formulations business in the market through new hirings.

"This expansion represents a pivotal moment in Morepen's journey as we sharpen our focus on the expanding domestic finished dosage market," Morepen Laboratories Chairman and MD Sushil Suri said in a statement.

With significant increase in the sales force and enhanced reach to doctors, pharmacies, and patients, the drugmaker is setting the stage for getting a bigger pie in the Indian pharmaceutical market valued at Rs 2.38 lakh crore, yielding higher gross margins and better returns for stakeholders in the long run, he added.

Currently, Morepen's formulation business stands around Rs 325 crore, and the company is targeting to touch Rs 1,000 crore in the next five years.

This goal will be supported by an aggressive expansion of the medical representative network and deeper market penetration across urban and rural India, with major growth expected from new products that the company is already producing at highly competitive costs, the company said.

The Indian pharmaceutical market is projected to reach USD 130 billion in 2030, with an expected annual growth rate of 8.2 per cent.

Morepen shares were trading 3.84 per cent up at Rs 49.97 apiece on the BSE.
Source: PTI
Read More On:
morepen laboratoriesmedical representativespharmaceutical marketformulations businessindia
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Andhra CM: Change Rules for Better Governance

Andhra Pradesh CM Naidu calls for business rule changes to improve governance and...

Pakistan Economy: IMF Projections & Debt Burden

IMF projects Pakistan's economy regains stability but faces high debt, weak investment,...

Vidya Wires IPO: Flat Debut, Jumps Over 12%

Vidya Wires shares debut flat, then jump over 12% against IPO price. IPO subscribed...

India Flight Duty Norms Restrictive: IATA

IATA DG says India's new flight duty regulations for pilots are more restrictive....

Aequs Shares Debut with Premium

Aequs shares listed with a 13% premium. IPO subscribed 101.63 times. Funds to repay...

Kalpataru Projects Bags Rs 2003 Cr Orders

Kalpataru Projects International Ltd (KPIL) secures new orders worth Rs 2003 crore in...

Meesho Shares Surge 46% in Market Debut

Meesho's stock jumps over 46% in its market debut. IPO subscribed 79 times. Company...

Stock Markets Rebound After Slump

Sensex and Nifty rebound in early trade after two days of decline. Value-buying boosts...

FTA Auto Component Duty: Assocham Prez Cautions

Assocham President warns against blanket duty cuts on auto components in EU FTA....

Rupee Falls to 90.07 Against US Dollar

Rupee depreciates to 90.07 against the US dollar amid trade talk anticipation and US...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com